Trial intelligence / Profile preview

Telemedicine management of COVID-19 in a supplementary health medical clinic in São Paulo

RBR-658khmRecruiting

Sponsor
Centro Medico Mazzei
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of hydroxychloroquine and azithromycin in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Centro Medico Mazzei. Started Apr 2020; status: recruiting.

02

Drugs

hydroxychloroquineazithromycin
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on RBR-658khm.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-658khm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call